insights_auto
Why is GNMSF down 5,28%?
Dive Deeperchevron_right
GNMSF:OTCMKTS
Genmab
USD 376,00
arrow_downward
-5,28%(-20,97) 1D
USD 372,30
arrow_downward
-0,98% (-3,70)todayPre-market
Closed: 6 Okt., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GNMSF...
Open
USD 382,60
High
USD 384,00
Low
USD 376,00
Mkt. cap
22,53 mjd
Avg. vol.
130,00
Volume
182,00
52-wk high
USD 396,97
52-wk low
USD 232,50
Beta
0,73
Shares outstanding
62,41 m
No. of employees
3 k
Open
USD 382,60
High
USD 384,00
Low
USD 376,00
Mkt. cap
22,53 mjd
Avg. vol.
130,00
Volume
182,00
52-wk high
USD 396,97
52-wk low
USD 232,50
Beta
0,73
Shares outstanding
62,41 m
No. of employees
3 k
News stories
From web sources and news partners
Stock Titan
·
3 uur gelede
Awarded cost-free, Genmab (GMAB)'s 5,300 board stock units vest after three years.
Yahoo Finance
·
3 uur gelede
Resolution Adopted at the Extraordinary General Meeting of Genmab A/S Including Grant of Restricted Stock Units to Board Members
Investing.com
·
8 uur gelede
H.C. Wainwright raises Genmab stock price target on positive trial data
TradingView
·
21 uur gelede
Genmab A/S Stock 12‑Month Price Target Raised to $42, Implies 9% Upside
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab